{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T19:26:10Z","timestamp":1758050770682,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81160294"],"award-info":[{"award-number":["81160294"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Science and Technology Research Program of Jiangxi Provincial Education Department","award":["GJJ13161"],"award-info":[{"award-number":["GJJ13161"]}]},{"name":"Key Project of Science and Technology Research Foundation of Hubei Province","award":["2007JX3A05"],"award-info":[{"award-number":["2007JX3A05"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.cellimm.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T12:52:34Z","timestamp":1434718354000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro antitumor immune response induced by dendritic cells transduced with human livin \u03b1 recombinant adenovirus"],"prefix":"10.1016","volume":"297","author":[{"given":"Junping","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangfang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengying","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaonan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellimm.2015.06.003_b0005","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1300","article-title":"Apoptosis and melanoma: molecular mechanisms","volume":"199","author":"Hussein","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.cellimm.2015.06.003_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/cbdd.12176","article-title":"Inhibitors of apoptotic proteins: new targets for anticancer therapy","volume":"82","author":"Saleem","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.cellimm.2015.06.003_b0015","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1073\/pnas.0530311100","article-title":"Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immunemediated tumor destruction","volume":"100","author":"Schmollinger","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.cellimm.2015.06.003_b0020","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00262-011-1124-1","article-title":"Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma","volume":"61","author":"Zhou","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2015.06.003_b0025","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1158\/1078-0432.1000.11.3","article-title":"Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin\/ML-IAP in lung cancer","volume":"11","author":"Hariu","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2015.06.003_b0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0014-5793(01)02366-3","article-title":"Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern","volume":"495","author":"Ashhab","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellimm.2015.06.003_b0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-0873-7","article-title":"Research progress on livin protein: an inhibitor of apoptosis","volume":"357","author":"Yan","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cellimm.2015.06.003_b0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jviromet.2013.04.013","article-title":"A rapid Q-PCR titration protocol for adenovirus and helper-dependent adenovirus vectors that produces biologically relevant results","volume":"192","author":"Gallaher","year":"2013","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.cellimm.2015.06.003_b0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1084\/jem.180.1.83","article-title":"Proliferating dendritic cell progenitors in human blood","volume":"180","author":"Romani","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cellimm.2015.06.003_b0050","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1016\/j.vaccine.2011.03.109","article-title":"Antitumour immunity mediated by mannan-modified adenovirus vectors expressing VE-cadherin","volume":"29","author":"Zhao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2015.06.003_b0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc3258","article-title":"Cancer immunotherapy via dendritic cells","volume":"12","author":"Palucka","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cellimm.2015.06.003_b0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00262-004-0611-z","article-title":"Identification of a potential human telomerase reverse transcriptase-derived, HLA-A1-restricted cytotoxic T-lymphocyte epitope","volume":"54","author":"Schreurs","year":"2005","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2015.06.003_b0065","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tibtech.2014.06.007","article-title":"Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells","volume":"32","author":"Eggermont","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.cellimm.2015.06.003_b0070","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.21203","article-title":"Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma","volume":"43","author":"Mizukoshi","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cellimm.2015.06.003_b0075","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1158\/1078-0432.CCR-05-2647","article-title":"Immunogenic HLA-B\u22170702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses","volume":"12","author":"Adot\u00e9vi","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cellimm.2015.06.003_b0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/0008-5472.CAN-12-1127","article-title":"Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination","volume":"73","author":"Aarntzen","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellimm.2015.06.003_b0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4049\/jimmunol.163.2.699","article-title":"Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens","volume":"163","author":"Kaplan","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2015.06.003_b0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/hum.2013.2527","article-title":"Adenovirus: the first effective in vivo gene delivery vector","volume":"25","author":"Crystal","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.cellimm.2015.06.003_b0095","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.vaccine.2011.02.027","article-title":"Dendritic cells transfected with PEG10 recombinant adenovirus elicit anti-tumor immune response in vitro and in vivo","volume":"29","author":"Peng","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2015.06.003_b0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.canlet.2010.11.005","article-title":"Dendritic cells engineered to express GITRL enhance therapeutic immunity in murine Lewis lung carcinoma","volume":"301","author":"Ma","year":"2011","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellimm.2015.06.003_b0105","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00432-007-0276-z","article-title":"Livin and Bcl-2 expression in high-grade osteosarcoma","volume":"134","author":"Nedelcu","year":"2008","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.cellimm.2015.06.003_b0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11010-008-9915-1","article-title":"The effects on cell growth and chemosensitivity by livin RNAi in non-small cell lung cancer","volume":"320","author":"Yuan","year":"2009","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cellimm.2015.06.003_b0115","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.lungcan.2009.07.007","article-title":"Antitumor effects of murine bone marrow-derived dendritic cells infected with xenogeneic livin alpha recombinant adenoviral vectors against Lewis lung carcinoma","volume":"68","author":"Xie","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cellimm.2015.06.003_b0120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00262-007-0327-y","article-title":"Dendritic cells modified with 6Ckine\/IFN gamma fusion gene induce specific cytotoxic T lymphocytes in vitro","volume":"56","author":"Xue","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cellimm.2015.06.003_b0125","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/ijc.21994","article-title":"Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma","volume":"119","author":"Kornacker","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.cellimm.2015.06.003_b0130","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/imm.12362","article-title":"Clinical implications of interferon-\u03b3 genetic and epigenetic variants","volume":"143","author":"Smith","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.cellimm.2015.06.003_b0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3389\/fimmu.2013.00409","article-title":"NKT cells as an ideal anti-tumor immunotherapeutic","volume":"4","author":"Fujii","year":"2013","journal-title":"Front. Immunol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:53:56Z","timestamp":1757804036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874915001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0008874915001227"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.06.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antitumor immune response induced by dendritic cells transduced with human livin \u03b1 recombinant adenovirus","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}